There are 5 resources available
Introduction
Presenter: Nicolas Girard
Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC
Resources:
Webcast
First things first: Identifying novel targets for non-oncogene-driven NSCLC
Presenter: Nicolas Girard
Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC
Resources:
Webcast
Leveraging the therapeutic timeline: Sequencing of ICIs and chemotherapy to derive treatment benefit after initial progression
Presenter: Andrea Ardizzoni
Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC
Resources:
Webcast
Time is ticking: A look at the prevailing unmet needs for second-line strategies in non-oncogene-driven NCSLC
Presenter: Alfredo Addeo
Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC
Resources:
Webcast
Closure
Presenter: Nicolas Girard
Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC
Resources:
Webcast